Publication Type : Journal Article
Thematic Areas : Nanosciences and Molecular Medicine
Publisher : Journal of Biomedical Nanotechnology
Source : Journal of Biomedical Nanotechnology, Volume 9, Number 3, p.335-347 (2013)
Keywords : 3 (4, 5 dimethyl 2 thiazolyl) 2, 5 diphenyltetrazolium bromide, animal cell, Animals, Anti-Androgen, apoptosis, article, blood compatibility, cancer cell, Cancer drug deliveries, Cell culture, Cell death, Cell Line, chitosan, chitosan derivative, concentration response, controlled drug release, controlled study, Dextran, dextran sulfate, Dextran sulphate, Dextrans, Diseases, drug cytotoxicity, Drug delivery, drug delivery system, Drug Delivery Systems, fibroblast, flow cytometry, fluorescence microscopy, Flutamide, Fourier Transform Infrared, Humans, in vitro study, lactate dehydrogenase, Light, male, Materials Testing, Mice, molecular imaging, nanoparticle, Nanoparticles, nonhuman, particle size, pH, prostate cancer, Prostate cancers, Prostatic Neoplasms, Radiation, Rhodamine 123, Scattering, Spectroscopy, Sulfur compounds, Thermogravimetry, Tumor, Whole Blood Coagulation Time
Campus : Kochi
School : Center for Nanosciences
Center : Amrita Center for Nanosciences and Molecular Medicine Move, Nanosciences
Department : Nanosciences
Verified : Yes
Year : 2013
Abstract : In the current work, a sustained drug delivery system of flutamide (FLT) was developed using chitosan (CS) and dextran sulphate (DS) nanoparticles and were characterized using different techniques. The prepared nanoparticles showed a size of 80-120 nm with an entrapment efficiency of 55±6.95%. In addition, blood compatibility, in vitro cytotoxicity, drug release and cellular uptake studies were also carried out. The drug release studies showed a sustained and pH dependent release pattern as a result, after 120 h about 66% drug release occurred at pH 7.4 and 78% release occurred in acidic pH. MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and LDH (lactate dehydrogenase) experiments proved the preferential toxicity of drug loaded nanoparticles towards prostate cancer cells (PC3) unlike in normal cells, mouse fibroblast cells (L929). The cell death mechanism of drug loaded nanoparticles for a concentration of 50 and 75 nM showed 28±2 and 35.2±4% apoptosis in samples treated with the PC3 cells after 24 h. Fluorescent microscopic imaging and flow cytometry confirmed the preferential uptake of the nanoparticles (NPs) in the prostate cancer cells (PC3) unlike in normal (L929) cells. Hence the developed FLT loaded CS-DS NPs could be used as a promising system for controlled delivery in prostate cancer. Copyright © 2013 American Scientific Publishers All rights reserved.
Cite this Research Publication : A. Anitha, Uthaman, S., Shantikumar V. Nair, Dr. Jayakumar Rangasamy, and Lakshmanan, V. - K., “Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer”, Journal of Biomedical Nanotechnology, vol. 9, pp. 335-347, 2013.